ARCHIVES

Revlimid Plus Steroid Effective In Clinical Trial

This article is from The Cancer Letter archive.

Vol. 30 No. 11 | November 30, 2007

Download PDF Visit The Full Archive

Related Articles

Advisors Voted For Provenge Approval Despite Fundamental Flaws In Trials.

April 13, 2007

Organizations Ask Senate To Increase NCI Appropriations, Order OMB To “Get Nose Out Of Tent”

May 2, 1986

Final Count On Funded CCOPs Probably Delayed for Months; Many To Continue Without NCI Money

April 24, 1987

RFP: Sole Source

May 12, 2000

NCI, FDA, Correlogic To Begin Large Trial Of Protein Pattern Diagnostic System for Ovarian Cancer

June 28, 2002

Randomization With Options Stimulates Sedmental Accrual

February 22, 1980